Not Yet RecruitingNCT07766473
First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD)
PHASE1 · PHASE2 · 24 planned enrolment
- Countries listed
- 1
- Registry update
- September 18, 2026
Program Identity
BETA-TT8-001
Exact source-linked program identifier and related public trial registrations.
Filamon LTD
BETA-TT8-001
1 exact source-linked registration. No aliases, synonyms, ownership, or cross-source equivalence are inferred.